All Stories

  1. Multi-Omics and Machine Learning Integration Identifies TYMP as a Peripheral Blood Biomarker and Therapeutic Target in Alzheimer’s Disease
  2. Pan-Cancer Landscape of CDK1 Uncovers Its Potential Prognostic Significance and Therapeutic Targeting in Adrenocortical Carcinoma
  3. Therapeutic potential of SSZ in modulating Alzheimer’s disease pathology: A multi-targeted experimental approach
  4. Unveiling bioactive compounds in kola nut seeds: GC-MS identification and computational analysis for anticancer potential
  5. Green synthesis of alginate-encapsulated silver nanoparticles and its utilization as anticancer and antimicrobial therapeutics
  6. Emerged SARS-CoV-2 intermediate hosts: The missing links from One Health perspective
  7. Curcumin-piperine nanoparticles mitigate cuprizone-induced cognitive impairment via antioxidant and anti-inflammatory mechanisms
  8. MicroRNAs: From Bench to Bedside Applications as Breast Cancer Therapeutics
  9. Network Pharmacology-Guided Identification of Therapeutic Targets and Pathways for Cancer Stem Cell Inhibition Across Multiple Cancer Types
  10. Role of Circular RNAs in Regulating Tumor Microenvironment, Epithelial Mesenchymal Transition, and Resistance to Cancer Therapy
  11. Nanotechnology-based drug delivery for breast cancer treatment: Current applications and future directions
  12. Unlocking the therapeutic potential of polyphenols: Promising advances and future directions in pancreatic cancer treatment
  13. A Novel Synergized Nanoformulation Revives the Activity of Ineffective Ceftibuten Antibiotic: Synthesis, Characterization, In Vitro Validation and Molecular Interactions Study
  14. Leveraging AI and Natural Compounds: Innovative Approaches in the Diagnosis and Treatment of Hepatocellular Carcinoma
  15. Computational Exploration of a Diverse Flavonoid Library for Targeted Allosteric Inhibition of AKT1 in Cancer Therapy
  16. Synthesis and Neurobehavioral Evaluation of a Potent Multitargeted Inhibitor for the Treatment of Alzheimer’s Disease
  17. Anticancer potential of Cu4O3 NPs against human ovarian teratocarcinoma: an in-vitro validation
  18. Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics
  19. Analysis of some flavonoids for inhibitory mechanism against cancer target phosphatidylinositol 3-kinase (PI3K) using computational tool
  20. Interlinking of diabetes mellitus and cancer: An overview
  21. Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy
  22. Husk-like Zinc Oxide Nanoparticles Induce Apoptosis through ROS Generation in Epidermoid Carcinoma Cells: Effect of Incubation Period on Sol-Gel Synthesis and Anti-Cancerous Properties
  23. Targeting a transcription factor NF-κB by green tea catechins using in silico and in vitro studies in pancreatic cancer
  24. Association of interleukin-18 promoter polymorphism with comorbid conditions of cardiovascular disease
  25. Correction: Tabrez et al. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression. Molecules 2022, 27, 5042
  26. Pharmacophore-based virtual screening approaches to identify novel molecular candidates against EGFR through comprehensive computational approaches and in-vitro studies
  27. Advancement of cancer immunotherapy using nanoparticles-based nanomedicine
  28. Investigating the anticancer efficacy of biogenic synthesized MgONPs: An in vitro analysis
  29. Where do T cell subsets stand in SARS-CoV-2 infection: an update
  30. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression
  31. Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview
  32. The Role of Natural Products and Their Multitargeted Approach to Treat Solid Cancer
  33. Identification of anticancer bioactive compounds derived from Ficus sp. by targeting Poly[ADP-ribose]polymerase 1 (PARP-1)
  34. Association of IL-6 promoter polymorphism hotspots (− 174G/C and − 572G/C) with cardiovascular disease risk factors
  35. Biosynthesis of ZnO NPs from pumpkin seeds’ extract and elucidation of its anticancer potential against breast cancer
  36. Evaluation of Anticancer Potential of Biogenic Copper Oxide Nanoparticles (CuO NPs) against Breast Cancer
  37. Biosynthesis of copper oxide nanoparticles and its therapeutic efficacy against colon cancer
  38. Flavonoids and PI3K/Akt/mTOR Signaling Cascade: A Potential Crosstalk in Anticancer Treatment
  39. Targeting PI3K/Akt/mTOR Pathway by Different Flavonoids: A Cancer Chemopreventive Approach
  40. Natural Products Homoharringtonine and Emetine Alkaloids as SARS-CoV-2 Treatment Options
  41. Polyphenols as anticancer agents: Toxicological concern to healthy cells
  42. Dissecting Sex‐Related Cognition between Alzheimer’s Disease and Diabetes: From Molecular Mechanisms to Potential Therapeutic Strategies
  43. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2
  44. Analysis of sugar composition and pesticides using HPLC and GC–MS techniques in honey samples collected from Saudi Arabian markets
  45. A critical transcription factor NF-κB as a cancer therapeutic target and its inhibitors as cancer treatment options
  46. Association of IL-10 Gene Polymorphism With IL-10 Secretion by CD4 and T Regulatory Cells in Human Leprosy
  47. Calcium-/Calmodulin-Dependent Protein Kinase IV (CAMKIV): A Multifunctional Enzyme and Its Role in Various Cancer: An Update
  48. Exploring Inhibitory Mechanisms of Green Tea Catechins as Inhibitors of a Cancer Therapeutic Target, Nuclear Factor-κB (NF-κB)
  49. Role of viruses, prions and miRNA in neurodegenerative disorders and dementia
  50. Interleukin-10 Producing Regulatory B Cells Transformed CD4+CD25− Into Tregs and Enhanced Regulatory T Cells Function in Human Leprosy
  51. Association of HCV mutated proteins and host SNPs in the development of hepatocellular carcinoma
  52. Consequence of HIV and HCV co-infection on host immune response, persistence and current treatment options
  53. Recent Development and Future Prospects of Plant-Based Vaccines
  54. Clinical pharmacokinetic study for the effect of glimepiride matrix tablets developed by quality by design concept
  55. Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015)
  56. Updates on Traditional Medicinal Plants for Hepatocellular Carcinoma
  57. Nanomaterial Induced Immune Responses and Cytotoxicity
  58. Hepatic Cancer Stem Cells and Signaling Pathways
  59. Docking Studies of Pakistani HCV NS3 Helicase: A Possible Antiviral Drug Target
  60. Biomarkers for virus-induced hepatocellular carcinoma (HCC)
  61. Anticancer Compound Plumbagin and Its Molecular Targets: A Structural Insight into the Inhibitory Mechanisms Using Computational Approaches
  62. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma
  63. Potential mechanisms of hepatitis B virus induced liver injury